Insider trades
Robert C. Goeltz II, CFO of Arcus Biosciences RCUS, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $855.9K. The latest trade was on 05/11.
Robert C. Goeltz II
CFO
- Company
- Arcus Biosciences RCUS
- First filing
- 23/01/25
- Trades
- 21 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$855.9K
- Last trade
- 05/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/11 | 05/12 | 7,763 sh | $25.63 | $198,965.69 | −8.4% | |
| Open-market sale10b5-1 plan | 25/12/31 | 01/02 | 6,552 sh | $23.38 | $153,185.76 | −8.8% | |
RCUS | Open-market sale10b5-1 plan | 25/12/16–25/12/17 | 25/12/18 | 12,662 sh2 trades | $22.01avg. | $278,713.36 | −14.5% |
| Open-market sale10b5-1 plan | 25/11/26 | 25/11/26 | 5,000 sh | $25.00 | $125,000 | −5.4% | |
| Open-market sale10b5-1 plan | 25/10/28 | 25/10/29 | 5,000 sh | $20.00 | $100,000 | −5.1% | |
| Open-market sale10b5-1 plan | 24/12/31 | 25/01/03 | 3,594 sh | $15.00 | $53,910 | −5.6% | |
| Open-market sale10b5-1 plan | 24/01/02 | 24/01/04 | 2,004 sh | $20.00 | $40,080 | −3.7% | |
| Open-market sale10b5-1 plan | 23/06/07 | 23/06/09 | 4,049 sh | $20.04 | $81,141.96 | −6.4% |